ScholarIQanswers from OpenAlex
Cancer Research UK
FunderResearch funding and supported work
Cancer Research UK is a funder indexed in ScholarIQ from OpenAlex.
What is known about Cancer Research UK?
ScholarIQrecord summary
charity which conducts research on cancer
How many works does Cancer Research UK have?
ScholarIQindexed works
Cancer Research UK has 64,304 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Cancer Research UK?
ScholarIQopenalex
The OpenAlex for Cancer Research UK is on the source record.
What is the ROR of Cancer Research UK?
ScholarIQror
The ROR for Cancer Research UK is on the source record.
What are the most-cited papers on Cancer Research UK?
ScholarIQmost cited works
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer
Dana W.Y. Tsui, Muhammed Murtaza, Alvin Wong, Oscar M. Rueda, Christopher G. Smith, Dineika Chandrananda, Ross A. Soo, Hong Liang Lim, Boon Cher Goh, Carlos Caldas, Tim Forshew, Davina Gale, Wei Liu, James Morris, Francesco Marass, Tim Eisen, Tan Min Chin, Nitzan Rosenfeld
Human papillomavirus vaccine acceptability among parents of adolescent girls: Obstacles and challenges in Mysore, India
Purnima Madhivanan, Li Tan, Vijaya Srinivas, Laura A.V. Marlow, Soumyadeep Mukherjee, Karl Krupp
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
Renée Schmitz, Alexandra W. van den Belt‐Dusebout, Karen Clements, Yi Ren, Chiara Cresta, Jasmine Timbres, Yat-Hee Liu, Danalyn Byng, Thomas R. Lynch, Brian A. Menegaz, Deborah Collyar, Terry Hyslop, Samantha M. Thomas, Jason K. Love, Michael Schaapveld, Proteeti Bhattacharjee, Marc D. Ryser, Elinor J. Sawyer, E. Shelley Hwang, Alastair M. Thompson, Jelle Wesseling, Esther H. Lips, Marjanka K. Schmidt
Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma <i>in situ</i>: observational cohort study
Sabrina M. Wang, Yan Li, Amanda L. Nash, Yi Ren, Samantha Thomas, Amanda B. Francescatti, Anne Barber, Thomas R. Lynch, Elizabeth S. Frank, Lars J. Grimm, Alastair M. Thompson, Ann H. Partridge, Terry Hyslop, Esther Hwang, Marc D. Ryser
What is the impact of targeted therapies given within phase I trials on the cognitive function of patients with advanced cancer: a mixed-methods exploratory study conducted in an early clinical trials unit
Sarah Stapleton, Anne‐Sophie Darlington, Johann S. de Bono, Theresa Wiseman